US Pharma MarketingFaeth’s PIKTOR plus paclitaxel combo gains FDA fast track status
Faeth Therapeutics has received fast track designation from the FDA for the PIKTOR with paclitaxel combination to treat advanced or recurrent endometrial cancer.
Faeth Therapeutics has received fast track designation from the FDA for the PIKTOR with paclitaxel combination to treat advanced or recurrent endometrial cancer.
Source: Pharmaceutical Technology